Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
The company develops expansion microscopy technology that enables nanoscale imaging of large brain tissue sections by permeating them with absorbent material and expanding with water, preserving molecular information.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Factor Bioscience develops mRNA, gene-editing, and cell-reprogramming technologies for cell engineering, including tools to repair disease-causing mutations and engineer immune cells to fight cancer. It works with strategic pharmaceutical and biotech partners across product development stages, from target identification through cell line development and manufacturing in its cleanrooms.
0 investors
0 investors
Far UV Technologies designs and manufactures germicidal UV light systems and environmental infection control products for reducing or eliminating pathogens in indoor spaces across healthcare, education, commercial, and transportation sectors. The company operates through its own technology and through AeroMed, Inc., a subsidiary with over 30 years of experience in infection control engineering.
0 investors
Biotechnology company developing CAR-T therapeutics using a novel M83 co-stimulatory domain platform for enhanced efficacy against solid tumors.
0 investors
0 investors
0 investors
0 investors
Veru is a biopharmaceutical company developing and commercializing treatments for cardiometabolic and oncology conditions. Its lead programs include enobosarm, an oral selective androgen receptor modulator aimed at preventing muscle loss in patients on GLP-1 weight loss therapy, and sabizabulin, an oral microtubule targeting agent for KRAS-driven metastatic pancreatic cancer resistant to existing therapy.
0 investors
Femasys develops office-based medical devices for women's healthcare, including first-line fertility treatments (FemaSeed, FemHSG catheter) delivered by OB/GYNs and fertility specialists, and a minimally invasive permanent birth control system (FemBloc). Its products aim to provide more affordable, less invasive alternatives to IVF and surgical contraception.
0 investors
FGH BioTech develops small molecule drugs that regulate SREBP transcription factors and related pathways, targeting the prevention and treatment of metabolic diseases and cancer. The company's work is based on decades of research in fat and energy metabolism.
0 investors
0 investors
FibroBiologics develops fibroblast cell-based therapies for chronic and degenerative conditions, targeting areas such as multiple sclerosis and other autoimmune diseases, degenerative disc disease, wound healing, and age-related organ decline (thymus and spleen). The company is a clinical-stage biotech positioning fibroblasts as an alternative to stem cells for regeneration and immune modulation.
0 investors
0 investors